$NOVN-CH News
Last published 6y ago
- 6y agoBNTXNOVN-CHPFEBioNTech buys German site from Novartis to boost vaccine outputCNBCGermany's BioNTech is purchasing a German biotech production site from Swiss drugs giant Novartis to boost output of the coronavirus vaccine hopeful it is developing with Pfizer.
- 6y agoNOVN-CHGOOGLStart-up that uses wearables to track whether drugs are effective gets $100 million infusion led by SoftBankCNBCSoftBank's investment into Biofourmis strikes a note of optimism for the troubled digital therapeutics space.
- 6y agoKOTPRLMTPM+12Stocks making the biggest moves in the premarket: Coca-Cola, Tapestry, Lockheed Martin & moreCNBCThe stocks making the biggest moves in premarket trading include Coca-Cola, Tapestry, Lockheed Martin, and more.
- 6y agoMCDTSLAJBLUFB+10Stocks making the biggest moves in the premarket: McDonald's, Tesla, JetBlue, Facebook & moreCNBCThe stocks making the biggest moves in premarket trading include McDonald's, Tesla, JetBlue, Facebook, and more.
- 6y agoNOVN-CHNovartis pays $729 million to settle U.S. kickback chargesCNBCNovartis agreed to pay more than $729 million to settle U.S. government charges it paid illegal kickbacks to doctors and patients to boost drug sales, the U.S. Department of Justice said on Wednesday.
- 6y agoGILDICPTSBUXKO+17Stocks making the biggest moves in the premarket: Gilead Sciences, Starbucks, BP, Coty & moreCNBCThe stocks making the biggest moves in premarket trading include Gilead Sciences, Starbucks, BP, Coty, and more.
- 6y agoMMMCATMRKPFE+16Stocks making the biggest moves in the premarket: 3M, Caterpillar, Pfizer, PepsiCo, Merck & moreCNBCThe stocks making the biggest moves in premarket trading include 3M, Caterpillar, Pfizer, PepsiCo, Merck, and more.
- 6y agoHSBA-GBBP.-GBSTNDFUBSG-CH+2European stocks head for mixed open as falling oil prices are in focusCNBCEuropean markets are heading towards a mixed open Tuesday as falling oil prices remain a focal points for investors.
- 6y agoBIIBGILDJNJPFE+2The market is rebounding on hope for a treatment, new index tracking coronavirus-drug makers showsCNBCA new CNBC index that tracks companies working on a Covid-19 cure shows how closely the stock market is following drug equities.
- 6y agoMSFTGEGOOGLNOVN-CH+2Microsoft hires a former GE exec to work with health companies in the midst of the coronavirus pandemicCNBCMicrosoft has been significantly expanding its health-care vertical, as the sector represents a major growth opportunity for its cloud business.
- 6y agoHALMTBDISPEP+12Stocks making the biggest moves in the premarket: Halliburton, Disney, PepsiCo, Walmart & moreCNBCThe stocks making the biggest moves in premarket trading include Halliburton, Disney, PepsiCo, Walmart, and more.
- 6y agoGILDSHAKNOVN-CH5 things to know before the stock market opens MondayCNBCDow futures point to a sharp drop at Monday's open as the May contract on West Texas Intermediate crude sinks more than 28%.
- 6y agoSTZDISMMMTSLA+12Stocks making the biggest moves in the premarket: Disney, 3M, Tesla, Apple, Peloton & moreCNBCThe stocks making the biggest moves in premarket trading include Disney, 3M, Tesla, Apple, Peloton, and more.
- 6y agoJNJCALMSAN-FRREGN+13Stocks making the biggest moves in the premarket: J&J, Sanofi, Regeneron, La-Z-Boy, Apple & moreCNBCThe stocks making the biggest moves in premarket trading include J&J, Sanofi, Regeneron, La-Z-Boy, Apple, and more.
- 6y agoBAMNOVN-CHCMG+20Member of Vice President Pence's office tests positive, US coronavirus cases now total more than 17,000CNBCAs of Friday, more than 259,000 cases of coronavirus have been reported worldwide, resulting in at least 11,000 deaths.
- 6y agoNOVN-CHAGNAZN-GBSAN-FR+1Coronavirus cases hit 80,370. Here's why the health sector is so woefully unpreparedCNBCOn Tuesday the number of confirmed coronavirus cases worldwide hit 80,370 and is continuing its global spread. The health sector, woefully unprepared to handle the outbreak, is trying to develop a vaccine. BioAegis Therapeutics' Steve Cordovano explains why the odds are against them.
- 6y agoNOVN-CHAMGNSAN-FRREGNNovartis strikes deal with UK to provide cholesterol drug to high-risk patientsCNBCThe Swiss drugmaker will provide the drug to patients with Atherosclerosis, a heart disease in which plaque builds up inside arteries and can lead to issues, including heart attack or death.